UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5301
TriNet
TNET
$3.05B
| $1.55M | ﹤0.01% |
31,304
-83,410
| -73% | -$3.58M |
2014 Q4
46 quarters
|
|
5302
Alto Neuroscience
ANRO
$987M
| $1.55M | ﹤0.01% |
58,697
+41,447
| +240% | +$958K |
2024 Q1
9 quarters
|
|
5303
RoboStrategy Inc
BOT
$529M
| $1.55M | ﹤0.01% |
+38,956
| New | +$1.2M |
2026 Q2
0 quarters
|
|
5304
JPMorgan Flexible Debt ETF
JFLX
$1.53B
| $1.55M | ﹤0.01% |
30,663
+22,786
| +289% | +$1.14M |
2025 Q3
3 quarters
|
|
5305
Palisade Bio
PALI
$197M
| $1.54M | ﹤0.01% |
737,307
-429,644
| -37% | -$846K |
2020 Q4
22 quarters
|
|
5306
CALL
Oscar Health
OSCR
$9.46B
| $1.54M | ﹤0.01% |
54,000
-220,500
| -80% | -$4.75M |
2025 Q2
4 quarters
|
|
5307
Arcos Dorados Holdings
ARCO
$1.47B
| $1.54M | ﹤0.01% |
190,608
-329,575
| -63% | -$2.85M |
2014 Q4
46 quarters
|
|
5308
PUT
Fortinet
FTNT
$87.3B
| $1.54M | ﹤0.01% |
10,000
-1,000
| -9% | -$116K |
2023 Q3
11 quarters
|
|
5309
Oil-Dri
ODC
$1.02B
| $1.53M | ﹤0.01% |
14,998
-14,791
| -50% | -$1.18M |
2019 Q2
28 quarters
|
|
5310
Optimum Communications Inc
OPTU
$287M
| $1.53M | ﹤0.01% |
1,054,580
+158,201
| +18% | +$197K |
2017 Q2
36 quarters
|
|
5311
Invesco DB US Dollar Index Bearish Fund
UDN
$95.1M
| $1.53M | ﹤0.01% |
85,462
-56,804
| -40% | -$1.03M |
2014 Q4
46 quarters
|
|
5312
Direxion Daily FTSE China Bull 3X ETF
YINN
$650M
| $1.53M | ﹤0.01% |
71,074
-12,586
| -15% | -$398K |
2020 Q2
24 quarters
|
|
5313
PUT
CME Group
CME
$109B
| $1.52M | ﹤0.01% |
6,900
-79,100
| -92% | -$21.9M |
2020 Q1
25 quarters
|
|
5314
iShares iBonds 2028 Term High Yield and Income ETF
IBHH
$482M
| $1.52M | ﹤0.01% |
64,822
+5,466
| +9% | +$128K |
2024 Q4
6 quarters
|
|
5315
Invesco Global Listed Private Equity ETF
PSP
$211M
| $1.52M | ﹤0.01% |
27,335
+508
| +2% | +$30.2K |
2014 Q4
46 quarters
|
|
5316
Mercantile Bank Corp
MBWM
$1.05B
| $1.52M | ﹤0.01% |
26,490
-9,149
| -26% | -$482K |
2016 Q2
40 quarters
|
|
5317
Koppers
KOP
$567M
| $1.52M | ﹤0.01% |
33,822
+1,216
| +4% | +$49.8K |
2014 Q4
46 quarters
|
|
5318
Bancroft Fund
BCV
$118M
| $1.52M | ﹤0.01% |
58,385
-2,488
| -4% | -$61.7K |
2014 Q4
46 quarters
|
|
5319
Perspective Therapeutics
CATX
$95.9M
| $1.52M | ﹤0.01% |
444,917
-75,988
| -15% | -$287K |
2015 Q1
45 quarters
|
|
5320
Defiance Daily Target 2x Long MSTR ETF
MSTX
$250M
| $1.52M | ﹤0.01% |
203,798
+203,474
| +62,801% | +$5.12M |
2024 Q4
6 quarters
|
|
5321
PUT
McCormick & Company Non-Voting
MKC
$13B
| $1.51M | ﹤0.01% |
+30,000
| New | +$1.47M |
2026 Q2
0 quarters
|
|
5322
Karat Packaging
KRT
$669M
| $1.51M | ﹤0.01% |
45,103
+20,389
| +82% | +$587K |
2021 Q2
20 quarters
|
|
5323
PUT
Caesars Entertainment
CZR
$5.96B
| $1.51M | ﹤0.01% |
50,000
-40,000
| -44% | -$1.13M |
2025 Q1
5 quarters
|
|
5324
Strata Critical Medical Inc
SRTA
$497M
| $1.5M | ﹤0.01% |
285,137
-8,456
| -3% | -$44.5K |
2020 Q3
23 quarters
|
|
5325
Liberty All-Star Equity Fund
USA
$1.84B
| $1.5M | ﹤0.01% |
258,483
-99,157
| -28% | -$572K |
2014 Q4
46 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.